Coadministration of mefloquine and chloroqine: use of a pharmacokinetic-based approach to reduce toxicity.

Pediatr Infect Dis J

Division of Clinical Pharmacology and Toxicology, Children's Mercy Hospital and Clinics, Kansas City, MO 64108, USA.

Published: February 2001

A child with malaria from a chloroquine-resistant area received an accidental overdose of chloroquine administered by a parent. Application of pharmacokinetics permitted definitive treatment with mefloquine in a safe and effective manner.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00006454-200102000-00023DOI Listing

Publication Analysis

Top Keywords

coadministration mefloquine
4
mefloquine chloroqine
4
chloroqine pharmacokinetic-based
4
pharmacokinetic-based approach
4
approach reduce
4
reduce toxicity
4
toxicity child
4
child malaria
4
malaria chloroquine-resistant
4
chloroquine-resistant area
4

Similar Publications

Background Alveolar echinococcosis (AE) is a fatal zoonotic disease distributed mainly in the Northern Hemisphere. At present, its curative treatment relies on surgery, and the development of effective drugs is needed. We previously demonstrated the anti-echinococcal effect of atovaquone (ATV) as a mitochondrial complex III inhibitor in both in vitro and in vivo experiments.

View Article and Find Full Text PDF

This study was designed to investigate the involvement of opioidergic/nitrergic systems in the anticonvulsant effect of mefloquine, compared with chloroquine, in mice. Seizures were induced by pentylenetetrazol and maximal electroshock. Mice were randomly subjected to receive mefloquine or chloroquine thirty minutes in advance.

View Article and Find Full Text PDF

Regulated rutin co-administration reverses mitochondrial-mediated apoptosis in Plasmodium berghei-infected mice.

Biochem Biophys Res Commun

February 2020

Laboratories for Biomembrane Research and Biotechnology, Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Nigeria.

Malarial infection causes apoptosis in hepatocytes. However, it is not known if co-administration of antimalarial drug with rutin will reverse the apoptotic effects of malarial infection. Plasmodium berghei-infected mice were assigned into groups as follows: groups I to III were treated with the vehicle (Parasitised Untreated, PU), 10 mg/kg body weight of Artesunate-Mefloquine (AM) and Dihydroartemisinin-Piperaquine (DP) respectively.

View Article and Find Full Text PDF

Background: Activation of hypnozoites of vivax malaria causes multiple clinical relapses, which contribute to the Plasmodium vivax burden and continuing transmission. Artemisinin-based combination therapy (ACT) is effective against blood-stage P. vivax but requires co-administration with primaquine to achieve radical cure.

View Article and Find Full Text PDF

Artemisinin-based combination therapies (ACTs) have contributed substantially to the global decline in morbidity and mortality, but resistance to artemisinins and their partner drugs is increasing in Southeast Asia, threatening malaria control. New antimalarial compounds will not be generally available soon. Combining three existing antimalarials in the form of triple ACTs, including dihydroartemisinin (DHA)-piperaquine + mefloquine, is a potential treatment option for multidrug-resistant malaria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!